J&J beats lawsuit alleging that talc caused three women's cancer - Yahoo Finance
J&J beats lawsuit alleging that talc caused three women's cancer Yahoo Finance
Ovarian Cancer News
Oxford University and Moderna launch trials of vaccine that could prevent cancer - The Independent
Oxford University and Moderna launch trials of vaccine that could prevent cancer The Independent
Oxford University and Moderna to trial pioneering cancer vaccine - The Independent
Oxford University and Moderna to trial pioneering cancer vaccine The Independent
Breakthrough ovarian cancer drug offers patients more time and better quality of life - BBC
Breakthrough ovarian cancer drug offers patients more time and better quality of life BBC
New ovarian cancer treatment approved for NHS - the first for 20 years - Sky News
New ovarian cancer treatment approved for NHS - the first for 20 years Sky News
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England - The Guardian
Life-prolonging drug for advanced ovarian cancer gets go-ahead in England The Guardian
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy - Reuters
British drug-cost watchdog recommends use of AbbVie's ovarian cancer therapy Reuters
Patient-Reported Outcomes Support Niraparib Maintenance in Advanced Ovarian Cancer Regardless of Homologous Recombination Deficiency Status - The ASCO Post
Patient-Reported Outcomes Support Niraparib Maintenance in Advanced Ovarian Cancer Regardless of Homologous Recombination Deficiency Status The ASCO Post
New targeted therapies aim to deliver chemotherapy more precisely for ovarian cancer - UCLA Health
New targeted therapies aim to deliver chemotherapy more precisely for ovarian cancer UCLA Health
Johnson & Johnson wins ovarian cancer talc lawsuit in California - Global Cosmetics News
Johnson & Johnson wins ovarian cancer talc lawsuit in California Global Cosmetics News
Carcinosarcoma of the Ovary Arising in the Background of a Mucinous Neoplasm Distinct From a Mural Nodule - Cureus
Carcinosarcoma of the Ovary Arising in the Background of a Mucinous Neoplasm Distinct From a Mural Nodule Cureus
NICE Clears New Drug for Platinum-Resistant Ovarian Cancer - Medscape
NICE Clears New Drug for Platinum-Resistant Ovarian Cancer Medscape
From bloating to irregular periods, 6 ovarian cancer symptoms you shouldn't ignore - The Times of India
From bloating to irregular periods, 6 ovarian cancer symptoms you shouldn't ignore The Times of India
J&J beats lawsuit alleging talc caused cancer in three women - Maryland Daily Record
J&J beats lawsuit alleging talc caused cancer in three women Maryland Daily Record
Ovarian Cancer: Closing Gaps and Advancing Care with RWD - Pharmaceutical Executive
Ovarian Cancer: Closing Gaps and Advancing Care with RWD Pharmaceutical Executive
Elizabethtown couple celebrates first year of marriage, cancer remission with UofL Hospital - WAVE News
Elizabethtown couple celebrates first year of marriage, cancer remission with UofL Hospital WAVE News
Rice University receives CPRIT funding to advance cancer research - News-Medical
Rice University receives CPRIT funding to advance cancer research News-Medical
CRISPR Shreds Undruggable Cancer Cells with Precision - Genetic Engineering and Biotechnology News
CRISPR Shreds Undruggable Cancer Cells with Precision Genetic Engineering and Biotechnology News
Treatment Options for Platinum-Resistant Ovarian Cancer - Everyday Health
Treatment Options for Platinum-Resistant Ovarian Cancer Everyday Health
Prosigna Scores, Ovarian Suppression, and Chemotherapy Omission: Iain MacPherson, PhD - AJMC
Prosigna Scores, Ovarian Suppression, and Chemotherapy Omission: Iain MacPherson, PhD AJMC
New ovarian cancer treatment dubbed ‘biological missile’ approved - Leader Publications
New ovarian cancer treatment dubbed ‘biological missile’ approved Leader Publications
Ovarian Cancer Jury Told Johnson & Johnson Hid Asbestos Test Results from FDA - Mesothelioma.net
Ovarian Cancer Jury Told Johnson & Johnson Hid Asbestos Test Results from FDA Mesothelioma.net
'Every minute counts when it comes to new ovarian cancer treatment' - BBC
'Every minute counts when it comes to new ovarian cancer treatment' BBC
ASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’ - Fierce Biotech
ASCO: Gilead touts ADC ovarian cancer data as proof Tubulis buyout was ‘a good deal’ Fierce Biotech
Evaluation of Physical Activity and Lifestyle Interventions During and After Chemotherapy for Ovarian Cancer: A Systematic Review of Patient Experiences and Clinical Outcomes - Cureus
Evaluation of Physical Activity and Lifestyle Interventions During and After Chemotherapy for Ovarian Cancer: A Systematic Review of Patient Experiences and Clinical Outcomes Cureus
NHS rolls out first new ovarian cancer drug in 20 years - EMJ
NHS rolls out first new ovarian cancer drug in 20 years EMJ
Rethinking ovarian cancer III: the past decade and future directions - Nature
Rethinking ovarian cancer III: the past decade and future directions Nature
Ovarian cancer cells use stress hormone signaling to shut down immune system: Newsroom - UT Southwestern Medical Center
Ovarian cancer cells use stress hormone signaling to shut down immune system: Newsroom UT Southwestern Medical Center
Oxford University and Moderna launch trials of vaccine that could prevent cancer - The Independent
Oxford University and Moderna launch trials of vaccine that could prevent cancer The Independent
New Life-Extending Drug for Women with Ovarian Cancer - EMJ
New Life-Extending Drug for Women with Ovarian Cancer EMJ
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer - Nature
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer Nature
Dr. Sandra Orsulic awarded $1.9M in grants to advance ovarian cancer research - UCLA Health
Dr. Sandra Orsulic awarded $1.9M in grants to advance ovarian cancer research UCLA Health
Treatment for chemotherapy-resistant ovarian cancer approved for NHS use - The Pharmaceutical Journal
Treatment for chemotherapy-resistant ovarian cancer approved for NHS use The Pharmaceutical Journal
New ovarian cancer treatment dubbed ‘biological missile’ approved - Northeast Mississippi Daily Journal
New ovarian cancer treatment dubbed ‘biological missile’ approved Northeast Mississippi Daily Journal
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene - Nature
ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer | Oncogene Nature
New ovarian cancer treatment dubbed ‘biological missile’ approved - themercury.com
New ovarian cancer treatment dubbed ‘biological missile’ approved themercury.com
ASCO 2026: Fasting boosts chemotherapy responses for ovarian cancer patients - Oncology Central
ASCO 2026: Fasting boosts chemotherapy responses for ovarian cancer patients Oncology Central
Oxford University and Moderna launch trials of vaccine that could prevent cancer - AOL.com
Oxford University and Moderna launch trials of vaccine that could prevent cancer AOL.com
Olympic Ice Dancer Piper Gilles Survived Ovarian Cancer. Here’s What to Know About the Disease. - CU Anschutz newsroom
Olympic Ice Dancer Piper Gilles Survived Ovarian Cancer. Here’s What to Know About the Disease. CU Anschutz newsroom
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome - Nature
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome Nature